Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed the day trading at $4.12 down -6.58% from the previous closing price of $4.41. In other words, the price has decreased by -$6.58 from its previous closing price. On the day, 0.67 million shares were traded. AMLX stock price reached its highest trading level at $4.49 during the session, while it also had its lowest trading level at $4.1.
Ratios:
For a better understanding of AMLX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.55. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Bedrosian Camille L sold 5,421 shares for $5.54 per share. The transaction valued at 30,007 led to the insider holds 138,380 shares of the business.
Klee Justin B. sold 18,589 shares of AMLX for $59,429 on Sep 30 ’24. The Co-Chief Executive Officer now owns 3,120,569 shares after completing the transaction at $3.20 per share. On Sep 30 ’24, another insider, Cohen Joshua B, who serves as the Co-Chief Executive Officer of the company, sold 18,589 shares for $3.20 each. As a result, the insider received 59,414 and left with 3,220,569 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 282417344 and an Enterprise Value of 50589184. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34 while its Price-to-Book (P/B) ratio in mrq is 1.44. Its current Enterprise Value per Revenue stands at 0.257 whereas that against EBITDA is -0.204.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $19.95, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -16.97%, while the 200-Day Moving Average is calculated to be 24.14%.
Shares Statistics:
Over the past 3-months, AMLX traded about 1.43M shares per day on average, while over the past 10 days, AMLX traded about 730790 shares per day. A total of 68.55M shares are outstanding, with a floating share count of 43.42M. Insiders hold about 36.66% of the company’s shares, while institutions hold 60.23% stake in the company. Shares short for AMLX as of 1732838400 were 1448789 with a Short Ratio of 1.02, compared to 1730332800 on 1289340. Therefore, it implies a Short% of Shares Outstanding of 1448789 and a Short% of Float of 2.32.
